n-Lorem Foundation

0 followers


n-Lorem’s mission is to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotides (ASO) medicines to treat patients with ultra-rare diseases (<10 patients).

Industries

Headquarters

Employees

Links

Org chart

Stanley T. Crooke
Founder And CEO

Stanley T. Crooke

Collapse
Sarah Glass
Chief Operating Officer
C. Frank Bennett
Chief Technical Officer
Joe Gleeson
Chief Medical Officer
Julie Douville
Executive Director, ASO Discovery & Development
Amy C. Williford
Senior Director Communications And Donor Relations
Laurence Mignon
Executive Director, Clinical Development
Cedrik Ngongang
Senior Director of Medical Geneticist